Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them | NEJM
Perspective from The New England Journal of Medicine — Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them
Related Articles
Can China & the US Avoid War? Seattle Event
Stabilizing US-China relations before a “near miss” turns into a crisis. Discussion with Quincy Institute & WPSR
Learn About Washington’s Nuclear Waste at the International Uranium Film Festival | South Seattle Emerald
The International Uranium Film Festival (IUFF) — dedicated to nuclear issues worldwide — runs from Friday, April 12, to Sunday, April 14, at the Northwest…
Advocating for a Healthy Response to Climate Change — COP28 and the Health Community | NEJM
At the recent COP28 climate negotiations in Dubai, participants from the health care and public health communities advocated for a focus on both health and…
Twenty-Five Years after Columbine — Firearms and Public Health in the United States | NEJM
Since the Columbine shooting, the gun problem in the United States has worsened, and the Supreme Court’s new interpretations of the Second Amendment don’t help.…
Bob Graham, former Florida governor and U.S. senator, dies at 87
Mr. Graham made a short-lived bid for the 2004 Democratic presidential nomination, campaigning largely on his opposition to the U.S.-led invasion of Iraq.
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) statement was published in 2015 to provide the minimum reporting recommendations…
Children of Ukraine
FRONTLINE examines how thousands of Ukrainian children have been taken and held in Russian-controlled territory since Russia’s 2022 invasion of Ukraine.
Sierra Leone’s first lady on gender-based violence and public health
During Women’s History Month, Sierra Leone First Lady Fatima Maada Bio spoke at The Studio at Harvard T.H.
FDA Takes Additional Steps to Advance Decentralized Clinical Trials
FDA is taking additional steps to advance decentralized clinical trials for drugs, biologics and devices.
The Threat of Florida’s New Legislation on Undocumented Individuals
This essay describes the author’s experience with a patient that illustrates what undocumented individuals living in Florida are experiencing due to Bill 1718.